Global Melatonin Market Size is $1488.81 Million in 2023

Global Melatonin Market Overview

According to global market monitor, it is estimated that global Melatonin market size was around 1488.81 M USD in 2023, and will reach 2587.96 M USD by 2028. CAGR of 11.10% from 2023-2028.

The busy lifestyle and increase in working hours lead to many health problems, such as neuralgia and weak immune system. A good sleep can alleviate these problems. Consumers today are choosing various nutritional supplements, including melatonin supplements. Therefore, creating innovative melatonin supplements with different characteristics and flavors may provide manufacturers with opportunities.

Melatonin Introduction

Melatonin is an endogenous neuroendocrine hormone produced by the pineal gland, which can issue "time signals" to the central nervous system through the mediation of specific receptors, thereby affecting the biological effect of time (namely circadian rhythm) of the body, regulating the sleep-wake period of the brain sleep center, and inducing natural sleep.

In the world, except for a few countries and regions such as the United States, melatonin is regarded as a functional food, and most countries (regions) such as the United Kingdom, France, Australia, and Japan are cautious about the use of melatonin, which is strictly controlled and cannot be sold at will in pharmacies. In the United Kingdom and Australia, melatonin is approved for the short-term treatment of primary insomnia in adults over 55 years of age. In Denmark and the Czech Republic, melatonin is banned in food supplements. In Belgium and Germany, products that provide 0.3 mg or more of melatonin per day are considered medicines based on their function.

Melatonin Market Segment

The classification of melatonin includes pharmaceutical grade and food grade. Pharmaceutical Grade segment accounted for the largest share of market. Due to the strong downstream demand, the proportion of food grade is on the rise during the forecast period.

Dietary Supplement is the main application of melatonin and it is on the rise. This is because it can be purchased without a prescription. Medical applications are second to Dietary Supplements.

Geographically, North America held the largest market share – 45.67% in 2021.

Segment by type	Pharmaceutical Grade Food Grade
	Pharmaceutical Grade segment accounted for the largest share
Segment by application	Dietary Supplements Medical Other
	Dietary Supplements segment occupied the biggest share
Segment by region	North America
	Europe
	Asia Pacific
	South America
	Middle East & Africa
	North America held the largest market share – 45.67% in 2021